ID: ALA428244

Max Phase: Preclinical

Molecular Formula: C25H32N4O7

Molecular Weight: 500.55

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@H]1CCc2cccc3c2N(C1=O)[C@H](C(=O)N[C@H](C=O)CC(=O)O)C3

Standard InChI:  InChI=1S/C25H32N4O7/c1-4-13(2)21(26-14(3)31)24(35)28-18-9-8-15-6-5-7-16-10-19(29(22(15)16)25(18)36)23(34)27-17(12-30)11-20(32)33/h5-7,12-13,17-19,21H,4,8-11H2,1-3H3,(H,26,31)(H,27,34)(H,28,35)(H,32,33)/t13-,17-,18-,19-,21-/m0/s1

Standard InChI Key:  PHKDXBRYQQCBAI-RUHZZDLRSA-N

Associated Targets(Human)

Granzyme B 52 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 500.55Molecular Weight (Monoisotopic): 500.2271AlogP: 0.08#Rotatable Bonds: 10
Polar Surface Area: 161.98Molecular Species: ACIDHBA: 6HBD: 4
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.70CX Basic pKa: CX LogP: -0.15CX LogD: -3.45
Aromatic Rings: 1Heavy Atoms: 36QED Weighted: 0.33Np Likeness Score: 0.28

References

1. Maryanoff BE, Costanzo MJ..  (2008)  Inhibitors of proteases and amide hydrolases that employ an alpha-ketoheterocycle as a key enabling functionality.,  16  (4): [PMID:18053726] [10.1016/j.bmc.2007.11.015]

Source